Publikationen am Institut für Zellbiologie und Biophysik

Publikationen in den Abteilungen

Gesamtliste

Zeige Ergebnisse 61 - 70 von 443

Schindler, J 2022, 'CRISPR/Cas9 vermittelter Connexin Knockout in humanen Epithelzelllinien'.
Segbehoe, LS, Schaarschmidt, F & Djira, GD 2022, 'Simultaneous confidence intervals for contrasts of quantiles', Biometrical Journal, Jg. 64, Nr. 1, S. 7-19. https://doi.org/10.1002/bimj.202000077
Zippel, S, Dilger, N, Chatterjee, C, Raic, A, Brenner-Weiß, G, Schadzek, P, Rapp, BE & Lee-Thedieck, C 2022, 'A parallelized, perfused 3D triculture model of leukemia for in vitro drug testing of chemotherapeutics', Biofabrication, Jg. 14, Nr. 3, 035011. https://doi.org/10.1088/1758-5090/ac6a7e
Alnajjar, S, Nolte, I, Becker, A, Schille, JT, Trakooljul, N, Frank, M, Ngezahayo, A & Murua Escobar, H 2021, 'Ablation of Red Stable Transfected Claudin Expressing Canine Prostate Adenocarcinoma and Transitional Cell Carcinoma Cell Lines by C-CPE Gold-Nanoparticle-Mediated Laser Intervention', International Journal of Molecular Sciences, Jg. 22, Nr. 22, 12289. https://doi.org/10.3390/ijms222212289, https://doi.org/10.3390/ijms222212289
Chatterjee, C, Schertl, P, Frommer, M, Ludwig-Husemann, A, Mohra, A, Dilger, N, Naolou, T, Meermeyer, S, Bergmann, TC, Calleja, AA & Lee-Thedieck, C 2021, 'Rebuilding the hematopoietic stem cell niche: recent developments and future prospects.', Acta biomaterialia, Jg. 132, S. 129-148. https://doi.org/10.1016/j.actbio.2021.03.061
Fneish, F, Schaarschmidt, F & Fortwengel, G 2021, 'Improving Risk Assessment in Clinical Trials: Toward a Systematic Risk-Based Monitoring Approach', Current Therapeutic Research - Clinical and Experimental, Jg. 95, 100643. https://doi.org/10.1016/j.curtheres.2021.100643
Glück, T, Biermann, T, Wolf, A, Budig, S, Ziebehl, A, Knöchelmann, M & Lachmayer, R 2021, 'Distraction Potential of Vehicle-Based On-Road Projection', Applied Sciences, Jg. 11, Nr. 24, 12030. https://doi.org/10.3390/app112412030
Hothorn, LA 2021 'A statistical method for estimating the no-observed-adverse-event-level'. https://doi.org/10.48550/arXiv.2101.00427
Hothorn, LA & Kropf, S 2021 'Closed testing procedures for treatment-versus-control comparisons and multiple correlated endpoint'. https://doi.org/10.48550/arXiv.2103.07661
Hothorn, LA 2021 'Simultaneous comparisons of treatments versus control (Dunnett-type tests) for location-scale alternatives'. https://doi.org/10.48550/arXiv.2103.06585